The tumor cells were lambda light chain restricted and positive for CD45, weakly positive for CD79a and negative for CD20, CD30, CD10, CD5, BCl-2, Bcl-6, Pax5 and S100, and consistent with anaplastic plasmacytoma. This evidence concerns the gene BCL2 and plasmacytoma.